# Study to Assess the Effect Of Alosetron On Mucosal Blood Flow

> **NCT00370032** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 49 (actual)

## Conditions studied

- Irritable Colon

## Interventions

- **DRUG:** alosetron

## Key facts

- **NCT ID:** NCT00370032
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2015-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370032, "Study to Assess the Effect Of Alosetron On Mucosal Blood Flow". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00370032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*